Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Kellie Sprague"'
Autor:
Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P. Chaulagain, Parul Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa Warner, Kenneth B. Miller, Lisa Lee, Cindy Varga, Raymond L. Comenzo
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-10 (2018)
Abstract Background The monoclonal antibody daratumumab, approved for treating myeloma, targets CD38, a protein on myeloma and also on CD34+ hematopoietic progenitor cells. Because mobilized CD34+ cells are critical for stem cell transplant, we inves
Externí odkaz:
https://doaj.org/article/364a62290fbf4b409d7bc9bdc5e061ec
Autor:
David Avigan, Martin S. Tallman, Mark R. Litzow, Kellie Sprague, Francine M. Foss, Henry N. Wagner, Xin Victoria Wang, Roger Strair, Sandra J. Horning, William J. Hogan, Randall D. Gascoyne, Opeyemi Jegede, Theresa L. Whiteside, Selina M. Luger, Daniel A. Arber, Hillard M. Lazarus, Edward A. Stadtmauer, Kenneth B. Miller
Publikováno v:
Transfusion
Background Extracorporeal photopheresis (ECP) is an immunomodulatory cellular therapy which has been shown to induce a tolerogenic state in patients with acute and chronic graft-vs-host disease. ECOG-ACRIN explored the activity of ECP as a part of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd62d39cf6ea830be2a42da9df24a59
https://doi.org/10.1111/trf.15798
https://doi.org/10.1111/trf.15798
Autor:
Hossein Sadrzadeh, Wanxing Chai-Ho, Parul Bhargava, Amir T. Fathi, Olga Pozdnyakova, Kellie Sprague, J. Mark Sloan, Peter Geon Kim, Benjamin J. Drapkin, Andrew M. Brunner
Publikováno v:
Leukemia Research. 74:47-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ce5e5d23b84fb9889a1c95f6c13c2c3
https://doi.org/10.1016/j.leukres.2018.09.008
https://doi.org/10.1016/j.leukres.2018.09.008
Autor:
Kellie Sprague, Andreas K. Klein, Esha Kaul, Janet M. Cowan, Monika Pilichowska, Kenneth B. Miller, Chakra P Chaulagain
Publikováno v:
Bone Marrow Transplantation
The risk of late complications including secondary malignancies is increased in long-term survivors of allogeneic hematopoietic stem cell transplants (HSCT). There is limited literature on the biological behavior and clinical features of squamous cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb0629956d40b25c767176d7590dde5
http://europepmc.org/articles/PMC6484708
http://europepmc.org/articles/PMC6484708
Autor:
Alejandro Moreno-Koehler, Sandy W. Wong, Michael E Coyle, Melissa Warner, Raymond L. Comenzo, Kenneth B. Miller, Deborah Black, Valerie Relias, Andrew M. Evens, Athena Kritharis, Andreas K. Klein, Terry Fogaren, Francois Toka, Denise Larivee, Kellie Sprague, Grace Kao, Nancy Cody Lyons
Publikováno v:
Cancer Treatment and Research Communications. 11:1-5
High-dose melphalan with autologous stem cell transplantation (SCT) has become a pillar of treatment for patients with multiple myeloma (MM). In the early era of SCT for MM, patients received oral alkylators and radiation, potential contributors to m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e1246fe48408193ce872e2440c6a196
https://doi.org/10.1016/j.ctarc.2017.02.002
https://doi.org/10.1016/j.ctarc.2017.02.002
Autor:
Kenneth B. Miller, Melissa Warner, Kellie Sprague, Andreas K. Klein, Sandy W. Wong, Xun Ma, Denis Toskic, Chakra P Chaulagain, Lisa Lee, Adin Kugelmass, Parul Doshi, Cindy Varga, Ping Zhou, Raymond Comenzo
Publikováno v:
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-10 (2018)
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-10 (2018)
Background The monoclonal antibody daratumumab, approved for treating myeloma, targets CD38, a protein on myeloma and also on CD34+ hematopoietic progenitor cells. Because mobilized CD34+ cells are critical for stem cell transplant, we investigated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22143d980b0b35f352b8b672698f2ba6
https://doi.org/10.1186/s40164-018-0119-4
https://doi.org/10.1186/s40164-018-0119-4
Autor:
Pei-Jung Lin, Raymond L. Comenzo, Kellie Sprague, Aaron N. Winn, Susan K. Parsons, Joshua T. Cohen, Gunjan L. Shah, Rachel J. Buchsbaum, Hedy Smith, Andreas K. Klein, Kenneth B. Miller
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:1823-1829
In the past decade, the number of autologous hematopoietic stem cell transplants (Auto HSCT) for older patients with multiple myeloma (MM) has increased dramatically, as has the cost of transplantation. The cost-effectiveness of this modality in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c1676e7e8fdc8aa7bb256838af0cb6
https://doi.org/10.1016/j.bbmt.2015.05.013
https://doi.org/10.1016/j.bbmt.2015.05.013
Autor:
Raymond L. Comenzo, Kellie Sprague, Terry Fogaren, Melissa Warner, Sandy W. Wong, Denise Larivee
Publikováno v:
Bone marrow transplantation. 52(6)
Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c4faad6a8757a61a8c7721d596f071
https://pubmed.ncbi.nlm.nih.gov/28394371
https://pubmed.ncbi.nlm.nih.gov/28394371
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S52-S53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e60be069566408896832b4198dc69ac
https://doi.org/10.1016/j.bbmt.2017.12.605
https://doi.org/10.1016/j.bbmt.2017.12.605
Autor:
Rachel J. Buchsbaum, Pei-Jung Lin, Andreas K. Klein, Kellie Sprague, Susan K. Parsons, Joshua T. Cohen, Gunjan L. Shah, Aaron N. Winn, Hedy Smith, Raymond L. Comenzo, Kenneth B. Miller
Publikováno v:
Bone Marrow Research
Bone Marrow Research, Vol 2016 (2016)
Bone Marrow Research, Vol 2016 (2016)
Comorbidity is more common in older patients and can increase the cost of care by increasing toxicity. Using the SEER-Medicare database from 2000 to 2007, we examined the costs and life-year benefit of Auto-HSCT for MM patients over the age of 65 by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed4ccaf2ec593a4491c756cec9e17cf